I read the preprint and the supplementary data and it is interesting, but what I can't find, and I don't know why they don't include it, is a breakdown of event

I read the preprint and the supplementary data and it is interesting, but what I can't find, and I don't know why they don't include it, is a breakdown of events in the primary outcomes. In this study, primary outcome was a combination of: hospitalization, urgent care visit, or emergency room visit. There were 10 in the placebo and 1 in the budesonide group. But I can't find whether those events, or what proportion, were hospitalizations vs ER vs urgent care visits. If I'm missing something someone please correct me. To me it would not be a great therapeutic option if, for example and I'm making this up, the budesonide group had 1 hospitalization and the placebo had 10 urgent care visits. Also the number of patients was ~146, would like to see much higher numbers to catch what's significant to me, which is percent hospitalization. If you read their methods they created the study under the assumption that "20% of COVID-19 patients would be severe", when it was designed back in March which is a bit high.